Troponin	0	8	B-Gene_or_gene_product
I	9	10	I-Gene_or_gene_product
inhibits	11	19	O
capillary	20	29	B-Cell
endothelial	30	41	I-Cell
cell	42	46	I-Cell
proliferation	47	60	O
by	61	63	O
interaction	64	75	O
with	76	80	O
the	81	84	O
cell	85	89	B-Cell
'	89	90	O
s	90	91	O
bFGF	92	96	B-Gene_or_gene_product
receptor	97	105	I-Gene_or_gene_product
.	105	106	O

Troponin	108	116	B-Gene_or_gene_product
I	117	118	I-Gene_or_gene_product
(	119	120	O
TnI	120	123	B-Gene_or_gene_product
)	123	124	O
is	125	127	O
a	128	129	O
novel	130	135	O
cartilage	136	145	O
-	145	146	O
derived	146	153	O
angiogenesis	154	166	O
inhibitor	167	176	O
,	176	177	O
first	178	183	O
demonstrated	184	196	O
by	197	199	O
Moses	200	205	O
et	206	208	O
al	209	211	O
.	211	212	O

(	213	214	O
1999	214	218	O
,	218	219	O
Proc	220	224	O
.	224	225	O
Natl	226	230	O
.	230	231	O
Acad	232	236	O
.	236	237	O
Sci	238	241	O
.	241	242	O
USA	243	246	O
2645	247	251	O
-	251	252	O
2650	252	256	O
)	256	257	O
to	258	260	O
inhibit	261	268	O
endothelial	269	280	B-Cell
cell	281	285	I-Cell
proliferation	286	299	O
and	300	303	O
angiogenesis	304	316	O
,	316	317	O
both	318	322	O
in	323	325	O
vivo	326	330	O
and	331	334	O
in	335	337	O
vitro	338	343	O
,	343	344	O
and	345	348	O
to	349	351	O
inhibit	352	359	O
metastasis	360	370	O
of	371	373	O
a	374	375	O
wide	376	380	O
variety	381	388	O
of	389	391	O
tumors	392	398	B-Pathological_formation
in	399	401	O
vivo	402	406	O
.	406	407	O

Despite	408	415	O
convincing	416	426	O
evidence	427	435	O
of	436	438	O
its	439	442	O
efficacy	443	451	O
,	451	452	O
little	453	459	O
is	460	462	O
known	463	468	O
about	469	474	O
the	475	478	O
mechanism	479	488	O
of	489	491	O
action	492	498	O
of	499	501	O
TnI	502	505	B-Gene_or_gene_product
as	506	508	O
an	509	511	O
anti	512	516	O
-	516	517	O
proliferative	517	530	O
and	531	534	O
anti	535	539	O
-	539	540	O
angiogenic	540	550	O
agent	551	556	O
.	556	557	O

In	558	560	O
the	561	564	O
current	565	572	O
article	573	580	O
we	581	583	O
demonstrate	584	595	O
that	596	600	O
TnI	601	604	B-Gene_or_gene_product
inhibits	605	613	O
both	614	618	O
bFGF	619	623	B-Gene_or_gene_product
-	623	624	O
stimulated	624	634	O
and	635	638	O
basal	639	644	O
levels	645	651	O
of	652	654	O
endothelial	655	666	B-Cell
cell	667	671	I-Cell
proliferation	672	685	O
,	685	686	O
and	687	690	O
we	691	693	O
hypothesize	694	705	O
that	706	710	O
this	711	715	O
inhibition	716	726	O
is	727	729	O
occurring	730	739	O
,	739	740	O
at	741	743	O
least	744	749	O
in	750	752	O
part	753	757	O
,	757	758	O
via	759	762	O
an	763	765	O
interaction	766	777	O
of	778	780	O
TnI	781	784	B-Gene_or_gene_product
with	785	789	O
the	790	793	O
cell	794	798	B-Cell
-	798	799	O
surface	799	806	O
bFGF	807	811	B-Gene_or_gene_product
receptor	812	820	I-Gene_or_gene_product
on	821	823	O
capillary	824	833	B-Cell
endothelial	834	845	I-Cell
cells	846	851	I-Cell
.	851	852	O

We	853	855	O
further	856	863	O
support	864	871	O
this	872	876	O
hypothesis	877	887	O
by	888	890	O
providing	891	900	O
the	901	904	O
first	905	910	O
evidence	911	919	O
that	920	924	O
TnI	925	928	B-Gene_or_gene_product
can	929	932	O
act	933	936	O
on	937	939	O
nonendothelial	940	954	B-Cell
as	955	957	O
well	958	962	O
as	963	965	O
endothelial	966	977	B-Cell
cells	978	983	I-Cell
and	984	987	O
by	988	990	O
demonstrating	991	1004	O
that	1005	1009	O
this	1010	1014	O
inhibitory	1015	1025	O
action	1026	1032	O
is	1033	1035	O
specific	1036	1044	O
for	1045	1048	O
the	1049	1052	O
bFGF	1053	1057	B-Gene_or_gene_product
receptor	1058	1066	I-Gene_or_gene_product
on	1067	1069	O
the	1070	1073	O
target	1074	1080	O
cells	1081	1086	B-Cell
.	1086	1087	O

Preliminary	1088	1099	O
data	1100	1104	O
suggest	1105	1112	O
that	1113	1117	O
TnI	1118	1121	B-Gene_or_gene_product
may	1122	1125	O
be	1126	1128	O
competing	1129	1138	O
with	1139	1143	O
bFGF	1144	1148	B-Gene_or_gene_product
for	1149	1152	O
interaction	1153	1164	O
with	1165	1169	O
the	1170	1173	O
bFGF	1174	1178	B-Gene_or_gene_product
receptor	1179	1187	I-Gene_or_gene_product
on	1188	1190	O
responsive	1191	1201	O
cells	1202	1207	B-Cell
.	1207	1208	O

